See the DrugPatentWatch profile for Vyepti
What are Vyepti (eptinezumab) contraindications?
Vyepti is contraindicated in people with a known hypersensitivity (serious allergic reaction) to eptinezumab or any of its ingredients. If a patient has had a prior severe reaction to Vyepti, it should not be used.
What counts as a contraindication vs. a warning for Vyepti?
A contraindication is a condition where the drug should not be used at all (for Vyepti, that’s known serious hypersensitivity). In practice, clinicians also watch closely for infusion- or allergy-related reactions, but those are typically handled as precautions/monitoring rather than absolute contraindications unless the patient has a documented severe hypersensitivity to the drug itself.
Who should not take Vyepti (practical screening before the first dose)?
Before prescribing or administering Vyepti, clinicians screen for:
- A history of serious allergic reaction to eptinezumab or Vyepti components
- Prior severe infusion-related reactions specifically attributed to Vyepti (which would fall under hypersensitivity)
Are there any other specific contraindications listed for Vyepti?
Based on available labeling information, the main contraindication is known hypersensitivity to eptinezumab or Vyepti’s ingredients. If you want, share the country (U.S., EU, etc.) or the exact label text you’re looking at, and I can align the contraindications to that specific official wording.
Sources
No sources were provided in the prompt.